Full-Time

Laboratory Testing Manager

Alliance

Updated on 9/3/2026

Deadline 6/10/27
Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center

1,001-5,000 employees

Nonprofit cancer treatment, research, and trials

Compensation Overview

$120.9k - $191.1k/yr

+ Relocation assistance

No H1B Sponsorship

Seattle, WA, USA

In Person

May include travel to other sites. Relocation assistance may be available.

Bachelor's, Master's

Category
Medical, Clinical & Veterinary
Required Skills
Inventory Management
Quality Assurance (QA)
Financial Modeling

Get referred to Fred Hutchinson Cancer Center

See people who can refer or advise you

Requirements
  • A bachelor's degree in a chemical, biological, clinical, or medical laboratory science, medical technology, or equivalent education and training as defined in 42CFR493.1489(b)(3) is required, and the candidate must meet CLIA education requirements for high-complexity testing.
  • Medical Laboratory Scientist, Medical Technologist, Histocompatibility Technologist, or equivalent certification is required, with certified continuing-education maintenance through ASCP, AMT, AAB, ABHI, or an equivalent agency.
  • Six years of accumulated clinical laboratory experience performing testing on human samples is required, including two years of training and experience in the designated discipline or area of service.
  • At least two years of previous experience in a lead, senior technician, or coordinator role, or one year of previous experience in a supervisor, manager, or director role verified by title, is required. A total of four years of clinical laboratory experience performing high-complexity testing may be acceptable in lieu of six total years for qualifying candidates.
  • Knowledge of Clinical Laboratory Improvement Amendments and College of American Pathologists regulations is required.
  • Demonstrated direct or indirect leadership of laboratory projects, such as new test validation, process improvement, or employee engagement, is required.
  • Good written and oral communication skills are required.
  • Proficiency with Microsoft Office Suite is required.
  • The ability to develop and present content to senior leaders and other groups is required.
  • Demonstrated experience with change management, conflict resolution, and complex problem solving is required.
  • The ability to work independently and exercise sound judgment is required.
Responsibilities
  • Manage the daily operations of Alliance Lab Testing Services at assigned laboratories and locations, including staff, quality control, and personnel.
  • Oversee personnel training, engagement, development, onboarding, and offboarding, and work with Human Resources on required personnel actions.
  • Coordinate laboratory operations with the Alliance Lab Technical and Compliance team, Specimen Processing teams, and other laboratory leadership.
  • Manage the laboratory quality improvement and quality assurance program in coordination with the Lab Quality team and the Alliance Lab Technical and Compliance team.
  • Participate in quality assurance and quality improvement planning, collect, monitor, and evaluate quality indicators, identify areas for improvement, and report to the Laboratory Quality Improvement and Integrity Committee.
  • Recruit, hire, train, and evaluate or re-evaluate technicians and technologists on the assigned team.
  • Coordinate Specimen Processing training as needed and maintain documentation of continuing competency and continuing education for laboratory staff.
  • Review and improve routine record keeping across assigned laboratories and locations, including maintenance, quality control, and temperature monitoring records.
  • Coordinate proficiency testing required by laboratory accrediting agencies.
  • Coordinate policy and procedure development, implementation, and revisions with the Alliance Lab Technical and Compliance team.
  • Represent Alliance Lab teams in laboratory information and information technology settings.
  • Implement safety rules and regulations in compliance with institutional, state, and federal standards and ensure continuous laboratory compliance.
  • Work with the Alliance Lab Leadership team on long-term planning for department operations, including staff and space needs and procedural changes.
  • Develop operating and capital budgets, monitor expenses and revenue, investigate budget variances, and report findings.
  • Manage instrumentation maintenance and inventories and recommend new laboratory instruments, related equipment, and supplies.
  • Represent the Alliance Lab at meetings with healthcare personnel and attend assigned committee meetings.
  • Serve as a liaison between the laboratory and other teams within Fred Hutch, the University of Washington, and external organizations.
  • Communicate technical and administrative information to appropriate faculty, directors, and staff.
  • Contribute to projects across departments and partner organizations, including possible travel to other sites.
  • Develop and monitor comprehensive productivity metrics and perform continuous analysis to achieve effective utilization of available resources.
  • Support the development and maintenance of adaptable laboratory systems for evolving clinical research needs.
  • Collaborate on strategic planning and implementation of infrastructure, workflows, and financial models supporting clinical research activities within the laboratory.
  • Assist Principal Investigators and research administration teams in aligning scientific goals with operational capabilities and fostering coordination and project success.
  • Provide training and guidance on clinical laboratory processes, procedures, and regulatory compliance as needed.
Desired Qualifications
  • A master's degree in laboratory science, healthcare administration, business, or a related field is preferred.
  • Meeting CLIA requirements for a general supervisor, technical consultant, and technical supervisor in hematology and/or chemistry is preferred.
  • CAP Inspection Team Member certification is preferred.
  • Familiarity with clinical research processes and their application in clinical laboratory settings is beneficial.
  • At least four years of laboratory training or experience, or both, in high-complexity testing in hematology and/or chemistry is preferred, or two years for employees with a qualifying master's degree.
  • Meeting CLIA training and experience requirements for a high-complexity general supervisor, technical consultant, and technical supervisor in hematology and/or chemistry is preferred.
  • Supervisory or lead experience is preferred.
  • Budget preparation and monitoring experience is preferred.
Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center

View

Fred Hutchinson Cancer Center is a nonprofit cancer treatment and research institute serving the Pacific Northwest and beyond. It provides a full range of cancer care, including treatments that may not be available elsewhere, and offers patients the chance to participate in clinical trials. The center accomplishes its work through a combination of patient care, research grants, and fundraising, and collaborates with UW Medicine and other regional providers to extend its reach. Internationally, it operates facilities in Uganda and South Africa to advance research and collaboration. The organization’s revenue comes from patient services, grants, and fundraising events. Its central goal is to eliminate cancer and related diseases by improving treatments and ultimately finding a cure.

Company Size

1,001-5,000

Company Stage

Grant

Total Funding

$300K

Headquarters

Seattle, Washington

Founded

1975

Get referred to Fred Hutchinson Cancer Center

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • PCORI awarded Fred Hutch $15 million in September 2026 for AML trials.
  • Fred Hutch launched eight CAIA pilot projects by March 2026 using de-identified clinical data.
  • Obliteride 2026 drew 6,400 participants, strengthening unrestricted community fundraising.

What critics are saying

  • At least seven data-breach class actions followed the November 2025 cyberattack.
  • The APP union election ended 54-54 on July 9, 2026, prolonging labor tension.
  • Dana-Farber, MSK, and Johns Hopkins can outcompete Fred Hutch for elite oncology talent.

What makes Fred Hutchinson Cancer Center unique

  • Fred Hutch leads the Cancer AI Alliance across four top cancer centers in 2026.
  • Its Seattle consortium with UW and Seattle Children's spans 600-plus faculty across disciplines.
  • Fred Hutch combines patient care, trials, and global research in Uganda and South Africa.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Paid Vacation

Paid Sick Leave

Paid Holidays

Paid Parental Leave

Sabbatical Leave

Tuition Reimbursement

Company News

Associated Press
Sep 3rd, 2026
Allen Institute, UW, and Fred Hutch launch AI BioDesign accelerator to decode biology's design rules

The Allen Institute, University of Washington, and Fred Hutch Cancer Center have launched AI BioDesign, a collaborative accelerator combining artificial intelligence with experimental biology to explore biological design space. The initiative aims to generate open models, datasets, and tools for creating biological solutions in healthcare, environmental challenges, and advanced technologies. AI BioDesign will operate through a continuous learning platform where AI models propose biological designs, scientists test them at scale, and results feed back into the models. The accelerator focuses on building modular models from tractable biological problems and conducting multiplex experiments. All models, datasets, assays, and benchmarks will be openly shared. The collaboration leverages Seattle's scientific ecosystem, combining the Allen Institute's open-science platforms, UW's synthetic biology expertise, and Fred Hutch's cellular systems knowledge. The project is supported by Fund for Science and Technology, a foundation in the Paul G. Allen philanthropic ecosystem.

Ensoma
Jul 16th, 2026
Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines

Company’s Engenious™ Vectors Delivered without Stem Cell Collection or Myeloablative Conditioning in Outpatient and Low-resource Settings, Enabling Access Worldwide

GeekWire
Apr 17th, 2025
Tech Moves: Smartsheet Names Chief Product Officer; Meta Vet Joins Tech Alliance; And More

Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Arora. (Smartsheet Photo)— Pratima Arora has been named chief product officer at Smartsheet, a new senior executive role at the Bellevue, Wash.-based enterprise software giant.A longtime product and technology leader, Arora will be responsible for Smartsheet’s product management, product marketing, user experience, pricing and packaging, and digital and product partnerships.She previously held senior leadership roles at Atlassian and Salesforce, and was most recently the chief product and technology officer at Chainalysis.“After a fantastic 4-month break to recharge, spend quality time with family, and dive deep into the world of GenAI, I’m energized and ready for what’s next,” Arora said on LinkedIn. “There’s no better place than Smartsheet to begin this new chapter. With a strong foundation, a passionate customer base, and a unique opportunity to reimagine collaborative work through AI, the road ahead is full of possibility.”Smartsheet also announced that Nick Dunn, an eight-year veteran of the company, is now general counsel, responsible for leading the company’s legal, privacy, and risk functions, including corporate governance initiatives.Launched in 2005, Smartsheet makes cloud-based enterprise work management technologies for managing and tracking projects, collaborating, storing data, and automating and assigning tasks, among other capabilities. It serves 85% of the Fortune 500 as customers

PR Newswire
Apr 4th, 2025
Google Cloud And Ai2 Commit $20M To Advance Ai-Powered Research For The Cancer Ai Alliance

Google Cloud to provide advanced and secure technology, while Ai2 to lead AI training and development for AI cancer modelsSEATTLE and SUNNYVALE, Calif., April 4, 2025 /PRNewswire/ -- Today, Google Cloud and Ai2 announced they have partnered with the Cancer AI Alliance (CAIA), a pioneering consortium uniting leading cancer research institutions and technology companies to harness artificial intelligence (AI) in the fight against cancer. Google Cloud and Ai2 are each giving $10 million to the initiative and providing access to technology solutions that will help speed scientific discovery. Google Cloud will power planet-scale AI infrastructure and data analytics tools, while Ai2 will provide critical expertise in training large-scale models focusing on cancer research

GeekWire
Apr 4th, 2025
Ai2 And Google Cloud Join Cancer Ai Alliance With A Total Of $20M In Commitments

Inside the Allen Institute for AI in Seattle. (GeekWire File Photo / Todd Bishop)The Allen Institute for AI (Ai2) is joining a high-profile national effort to accelerate cancer research using artificial intelligence, committing $10 million in researcher time and technical expertise to the Cancer AI Alliance, a consortium led by the Fred Hutch Cancer Center.Google Cloud is also committing $10 million in resources to the effort, planning to provide computing infrastructure and tools to help process large volumes of cancer data. They say the goal is to create a novel AI infrastructure that supports the training and deployment of AI models across institutions while maintaining data security and privacy standards for patients.The Cancer AI Alliance was announced in October 2024 as a joint effort among four major cancer centers: Fred Hutch, Dana-Farber, Memorial Sloan Kettering, and Johns Hopkins. Backed by more than $40 million in initial support from AWS, Microsoft, NVIDIA, Deloitte, and Slalom, the project aims to use artificial intelligence to analyze large volumes of cancer data across institutions. Seattle-based Fred Hutch is serving as the lead coordinating center.Ai2 CEO Ali Farhadi in his Seattle office. (GeekWire File Photo / Todd Bishop)In a previous interview with GeekWire, Ai2 CEO Ali Farhadi said the Cancer AI Alliance represents the kind of real-world challenge that needs customized, domain-specific AI models. The Seattle-based AI institute focuses on open-source artificial intelligence technologies.Farhadi said Ai2’s role in the Cancer AI Alliance reflects Ai2’s goal to apply cutting-edge research where it can have the most tangible impact on the world.“Any step in the right direction in that space is going to be a risk worth taking, and that’s the kind of impact that we’re after,” Farhadi said, explaining Ai2’s ambitions for 2025 on the GeekWire Podcast. “If you’re actually trying to solve a real problem, there is no turnkey solution.”The Cancer AI Alliance has said it expects initial research results by the end of 2025